United States (US) Opioids Market (2025-2031) | Industry, Size & Revenue, Analysis, Value, Forecast, Competitive Landscape, Growth, Trends, Share, Companies, Segmentation, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Opioids Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Opioids Market - Industry Life Cycle

3.4 United States (US) Opioids Market - Porter's Five Forces

3.5 United States (US) Opioids Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) Opioids Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic pain conditions in the US population

4.2.2 Rising awareness and acceptance of opioids for pain management

4.2.3 Growing demand for opioids in the treatment of cancer-related pain

4.2.4 Expansion of the elderly population requiring pain management

4.2.5 Technological advancements leading to the development of new opioid formulations

4.3 Market Restraints

4.3.1 Stringent regulations and policies surrounding opioid prescribing and dispensing

4.3.2 Public health concerns and backlash against opioid addiction and abuse

4.3.3 Increasing competition from alternative pain management therapies

4.3.4 Rising preference for non-opioid pain management options

4.3.5 Negative media coverage impacting the perception of opioids

6.1 United States (US) Opioids Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Opioids Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) Opioids Market Revenues & Volume, By Immediate Release/ Short Acting Opioids, 2021- 2031F

6.1.4 United States (US) Opioids Market Revenues & Volume, By Extended Release/Long Acting Opioids, 2021- 2031F

6.2 United States (US) Opioids Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Opioids Market Revenues & Volume, By Pain Relief, 2021- 2031F

6.2.3 United States (US) Opioids Market Revenues & Volume, By Anesthesia, 2021- 2031F

6.2.4 United States (US) Opioids Market Revenues & Volume, By Cough Suppression, 2021- 2031F

6.2.5 United States (US) Opioids Market Revenues & Volume, By Diarrhoea Suppression, 2021- 2031F

6.2.6 United States (US) Opioids Market Revenues & Volume, By De-addiction, 2021- 2031F

7.1 United States (US) Opioids Market Export to Major Countries

7.2 United States (US) Opioids Market Imports from Major Countries

8.1 Prescription rates of opioids for chronic pain management

8.2 Number of opioid-related overdose deaths and hospitalizations

8.3 Patient satisfaction and outcomes with opioid therapy

8.4 Adoption rates of abuse-deterrent opioid formulations

8.5 Investment in research and development of non-opioid pain management solutions

9.1 United States (US) Opioids Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) Opioids Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United States (US) Opioids Market Revenue Share, By Companies, 2024

10.2 United States (US) Opioids Market Competitive Benchmarking, By Operating and Technical Parameters